The breakthrough of the microbiota
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The microbiota, especially the gut microbiota, affects responses to several cancer therapies.
“recent insights importantly highlight the impact of microbiota (particularly the gut microbiota) on responses across several cancer therapies”
From The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy (2018) · cites this paper as Kroemer and Zitvogel, 2018
Cites
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Routy, B., Le Chatelier, E., Derosa, L., Duong, C. P. M., Alou, M. T., Daillère, R., Fluckiger, A., Messaoudene, M., Rauber, C., Roberti, M. P., et al. (2018) · Science · doi:10.1126/science.aan3706 · Cited by 5,671 · see citing works
Self-citationGut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
Gopalakrishnan, V., Spencer, C. N., Nezi, L., Reuben, A., Andrews, M. C., Karpinets, T. V., Prieto, P. A., Vicente, D., Hoffman, K., Wei, S. C., et al. (2018) · Science · doi:10.1126/science.aan4236 · Cited by 4,812 · see citing works
Self-citationThe commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients
Matson, V., Fessler, J., Bao, R., Chongsuwat, T., Zha, Y., Alegre, M.-L., Luke, J. J., & Gajewski, T. F. (2018) · Science · doi:10.1126/science.aao3290 · Cited by 3,107 · see citing works
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
Yu, T., Guo, F., Yu, Y., Sun, T., Ma, D., Han, J., Qian, Y., Kryczek, I., Sun, D., Nagarsheth, N., et al. (2017) · Cell · doi:10.1016/j.cell.2017.07.008 · Cited by 2,198 · see citing works
Geller, L. T., Barzily-Rokni, M., Danino, T., Jonas, O. H., Shental, N., Nejman, D., Gavert, N., Zwang, Y., Cooper, Z. A., Shee, K., et al. (2017) · Science · doi:10.1126/science.aah5043 · Cited by 1,817 · see citing works
A single-cell survey of the small intestinal epithelium
Haber, A. L., Biton, M., Rogel, N., Herbst, R. H., Shekhar, K., Smillie, C., Burgin, G., Delorey, T. M., Howitt, M. R., Katz, Y., et al. (2017) · Nature · doi:10.1038/nature24489 · Cited by 1,750 · see citing works
Analysis of <i>Fusobacterium</i> persistence and antibiotic response in colorectal cancer
Bullman, S., Pedamallu, C. S., Sicinska, E., Clancy, T. E., Zhang, X., Cai, D., Neuberg, D., Huang, K., Guevara, F., Nelson, T., et al. (2017) · Science · doi:10.1126/science.aal5240 · Cited by 1,574 · see citing works
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
Initiative, A. P. C. G., Balachandran, V. P., Łuksza, M., Zhao, J. N., Makarov, V., Moral, J. A., Remark, R., Herbst, B., Askan, G., Bhanot, U., et al. (2017) · Nature · doi:10.1038/nature24462 · Cited by 1,191 · see citing works
Mining the Human Gut Microbiota for Immunomodulatory Organisms
Geva-Zatorsky, N., Sefik, E., Kua, L., Pasman, L., Tan, T. G., Ortiz-Lopez, A., Yanortsang, T. B., Yang, L., Jupp, R., Mathis, D., et al. (2017) · Cell · doi:10.1016/j.cell.2017.01.022 · Cited by 762 · see citing works
Anticancer effects of the microbiome and its products
Zitvogel, L., Daillère, R., Roberti, M. P., Routy, B., & Kroemer, G. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.44 · Cited by 538 · see citing works
Self-citationIntestinal Microbiota and Relapse After Hematopoietic-Cell Transplantation
Peled, J. U., Devlin, S. M., Staffas, A., Lumish, M., Khanin, R., Littmann, E. R., Ling, L., Kosuri, S., Maloy, M., Slingerland, J. B., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.70.3348 · Cited by 325 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
Jiang, P., Gu, S., Pan, D., Fu, J., Sahu, A., Hu, X., Li, Z., Traugh, N., Bu, X., Li, B., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0136-1 · Cited by 5,179 · see citing works
The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy
Gopalakrishnan, V., Helmink, B. A., Spencer, C. N., Reuben, A., & Wargo, J. A. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.015 · Cited by 1,392 · see citing works
Nanoparticles for Cancer Therapy: Current Progress and Challenges
Gavas, S., Quazi, S., & Karpiński, T. M. (2021) · Nanoscale Research Letters · doi:10.1186/s11671-021-03628-6 · Cited by 1,069 · see citing works
Gut microbiota modulation: a novel strategy for prevention and treatment of colorectal cancer
Fong, W., Li, Q., & Yu, J. Q. (2020) · Oncogene · doi:10.1038/s41388-020-1341-1 · Cited by 625 · see citing works
Derosa, L., Routy, B., Fidelle, M., Iebba, V., Alla, L., Pasolli, E., Segata, N., Desnoyer, A., Pietrantonio, F., Ferrere, G., et al. (2020) · European Urology · doi:10.1016/j.eururo.2020.04.044 · Cited by 398 · see citing works
Self-citationControl of Immunity by the Microbiota
Ansaldo, E., Farley, T. K., & Belkaid, Y. (2021) · Annual Review of Immunology · doi:10.1146/annurev-immunol-093019-112348 · Cited by 299 · see citing works
Oliva, M., Spreafico, A., Taberna, M., Alemany, L., Coburn, B. A., Mesı́a, R., & Siu, L. L. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy507 · Cited by 261 · see citing works
Multi-omics data integration considerations and study design for biological systems and disease
Graw, S., Chappell, K., Washam, C. L., Gies, A. J., Bird, J. T., Robeson, M. S., & Byrum, S. D. (2020) · Molecular Omics · doi:10.1039/d0mo00041h · Cited by 223 · see citing works
New opportunities for nanoparticles in cancer immunotherapy
Park, W., Heo, Y.-J., & Han, D. K. (2018) · Biomaterials Research · doi:10.1186/s40824-018-0133-y · Cited by 222 · see citing works
The Molecular Hallmarks of the Serrated Pathway in Colorectal Cancer
Palma, F. D. E. D., D’Argenio, V., Pol, J. G., Kroemer, G., Maiuri, M. C., & Salvatore, F. (2019) · Cancers · doi:10.3390/cancers11071017 · Cited by 212 · see citing works
Self-citationLee, P.-C., Wu, C.-J., Hung, Y.-W., Lee, C. J., Chi, C.-T., Lee, I.-C., Yu-Lun, K., Chou, S.-H., Luo, J.-C., Hou, M.-C., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-004779 · Cited by 217 · see citing works
Gao, A., Chen, B., Gao, J., Zhou, F., Saeed, M., Hou, B., Li, Y., & Yu, H. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b04012 · Cited by 198 · see citing works
Gold Nanoparticles: Construction for Drug Delivery and Application in Cancer Immunotherapy
Huang, H., Liu, R., Yang, J., Dai, J., Fan, S., Pi, J., Wei, Y., & Guo, X. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15071868 · Cited by 197 · see citing works
Sex Differences in Cancer Immunotherapy Efficacy, Biomarkers, and Therapeutic Strategy
Wang, S., Cowley, L. A., & Liu, X. (2019) · Molecules · doi:10.3390/molecules24183214 · Cited by 177 · see citing works
Immunotherapy: A Challenge of Breast Cancer Treatment
García‐Aranda, M., & Redondo, M. (2019) · Cancers · doi:10.3390/cancers11121822 · Cited by 175 · see citing works
Melaiu, O., Chierici, M., Lucarini, V., Jurman, G., Conti, L. A., Vito, R. D., Boldrini, R., Cifaldi, L., Castellano, A., Furlanello, C., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19781-y · Cited by 163 · see citing works
Polyphenols: Immunomodulatory and Therapeutic Implication in Colorectal Cancer
Mileo, A. M., Nisticò, P., & Miccadei, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00729 · Cited by 152 · see citing works
Exploring the Emerging Role of the Gut Microbiota and Tumor Microenvironment in Cancer Immunotherapy
Qiu, Q., Lin, Y., Ma, Y., Li, X., Liang, J. B., Chen, Z., Liu, K., Huang, Y., Luo, H., Huang, R., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.612202 · Cited by 137 · see citing works
Liu, Y., Baba, Y., Ishimoto, T., Tsutsuki, H., Zhang, T., Nomoto, D., Okadome, K., Yamamura, K., Harada, K., Eto, K., et al. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-01198-5 · Cited by 132 · see citing works
Host and microbiome multi-omics integration: applications and methodologies
Wang, Q., Wang, K., Wu, W., Giannoulatou, E., Ho, J. W. K., & Li, L. (2019) · Biophysical Reviews · doi:10.1007/s12551-018-0491-7 · Cited by 122 · see citing works
Immune Escape during Breast Tumor Progression
del Alcazar, C. R. G., Alečković, M., & Polyák, K. (2020) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-19-0786 · Cited by 119 · see citing works
The Impact of Intratumoral and Gastrointestinal Microbiota on Systemic Cancer Therapy
Cogdill, A. P., Gaudreau, P. O., Arora, R., Gopalakrishnan, V., & Wargo, J. A. (2018) · Trends in Immunology · doi:10.1016/j.it.2018.09.007 · Cited by 98 · see citing works
Gut microbiota reshapes cancer immunotherapy efficacy: Mechanisms and therapeutic strategies
Xie, J., Liu, M., Deng, X., Tang, Y., Zheng, S., Ou, X., Tang, H., Xie, X., Wu, M., & Zou, Y. (2024) · iMeta · doi:10.1002/imt2.156 · Cited by 99 · see citing works
Wu, P., Han, J., Gong, Y., Liu, C., Yu, H., & Xie, N. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14101990 · Cited by 95 · see citing works
Mucosal-associated invariant T cells for cancer immunotherapy
Li, Y.-R., Zhou, K., Wilson, M., Kramer, A. B., Zhu, Y., Dawson, N., & Yang, L. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.11.019 · Cited by 93 · see citing works
Der prädiktive Wert der PD-L1-Diagnostik
Schildhaus, H. (2018) · Der Pathologe · doi:10.1007/s00292-018-0507-x · Cited by 92 · see citing works
Nanoparticles as Smart Carriers for Enhanced Cancer Immunotherapy
Thakur, N., Thakur, S., Chatterjee, S., Das, J., & Sil, P. C. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.597806 · Cited by 88 · see citing works
The evolving landscape of sex-based differences in lung cancer: a distinct disease in women
Ragavan, M. V., & Patel, M. I. (2022) · European Respiratory Review · doi:10.1183/16000617.0100-2021 · Cited by 88 · see citing works
Underlying Causes and Therapeutic Targeting of the Inflammatory Tumor Microenvironment
Comen, E. A., Bowman, R. L., & Kleppe, M. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00056 · Cited by 84 · see citing works
Zhang, X., Chen, X., Guo, Y., Gao, G., Wang, D., Wu, Y., Liu, J., Liang, G., Zhao, Y., & Wu, F. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202102059 · Cited by 78 · see citing works
The gut microbiome and efficacy of cancer immunotherapy
Roviello, G., Iannone, L. F., Bersanelli, M., Mini, E., & Catalano, M. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107973 · Cited by 75 · see citing works
Zhou, F., Gao, J., Xu, Z., Li, T., Gao, A., Sun, F. Z., Wang, F., Wang, W., Geng, Y., Zhang, F., et al. (2020) · Nano Today · doi:10.1016/j.nantod.2020.101025 · Cited by 71 · see citing works
Martini, G., Ciardiello, D., Dallio, M., Famiglietti, V., Esposito, L., Corte, C. M. D., Napolitano, S., Fasano, M., Gravina, A. G., Romano, M., et al. (2022) · International Journal of Cancer · doi:10.1002/ijc.34033 · Cited by 69 · see citing works
Lauté-Caly, D. L., Raftis, E. J., Cowie, P., Hennessy, E., Holt, A., Panzica, D. A., Sparre, C., Minter, B., Stroobach, E., & Mulder, I. E. (2019) · Scientific Reports · doi:10.1038/s41598-018-36926-8 · Cited by 67 · see citing works
Cancer immune exclusion: breaking the barricade for a successful immunotherapy
Bruni, S., Mercogliano, M. F., Mauro, F. L., Russo, R. I. C., & Schillaci, R. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1135456 · Cited by 66 · see citing works
Borcherding, N. C., Kolb, R. H., Gullicksrud, J. A., Vikas, P., Zhu, Y., & Zhang, W. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.05.030 · Cited by 60 · see citing works
Obiedat, A., Seidel, E., Mahameed, M., Bernani, O., Tsukerman, P., Voutetakis, K., Chatziioannou, A., Mcmahon, M., Avril, T., Chevet, E., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201801350rr · Cited by 51 · see citing works
Microbiota transplantation: Targeting cancer treatment
Wu, X., Zhang, T., Chen, X., Ji, G., & Zhang, F. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.03.010 · Cited by 63 · see citing works
Emerging Prospects for Nanoparticle‐Enabled Cancer Immunotherapy
Buabeid, M. A., Arafa, E. A., & Murtaza, G. (2020) · Journal of Immunology Research · doi:10.1155/2020/9624532 · Cited by 59 · see citing works
Melo, A. M., O’Brien, A., Phelan, J. J., Kennedy, S. A., Wood, N., Veerapen, N., Besra, G. S., Clarke, N. E., Foley, E. K., Ravi, A., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01580 · Cited by 57 · see citing works
Exploring the Modulatory Effects of Gut Microbiota in Anti-Cancer Therapy
Li, W., Deng, X., & Chen, T. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.644454 · Cited by 54 · see citing works
Sansone, C., Bruno, A., Piscitelli, C., Baci, D., Fontana, A., Brunet, C., Noonan, D. M., & Albini, A. (2021) · Cells · doi:10.3390/cells10020231 · Cited by 53 · see citing works
Multifaceted Roles of Mitochondrial Components and Metabolites in Metabolic Diseases and Cancer
Nakhle, J., Rodriguez, A., & Vignais, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124405 · Cited by 51 · see citing works
Recent advances in porous nanomaterials-based drug delivery systems for cancer immunotherapy
Li, S.-R., Huo, F., Wang, H., Wang, J., Xu, C., Liu, B., & Bu, L. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01489-4 · Cited by 51 · see citing works
Dumont-Leblond, N., Veillette, M., Racine, C., Joubert, P., & Duchaine, C. (2021) · PLoS ONE · doi:10.1371/journal.pone.0249832 · Cited by 49 · see citing works
Gut microbiome and cancer immunotherapy
Sun, J., Yin, T., Zhou, J., Jiang, X., & Lu, X. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29359 · Cited by 48 · see citing works
Inhibition of Cancer Development by Natural Plant Polyphenols: Molecular Mechanisms
Lyubitelev, A. V., & Studitsky, V. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310663 · Cited by 50 · see citing works
Principles of Molecular Utility for CMS Classification in Colorectal Cancer Management
Rejali, L., Asl, R. S., Sanjabi, F., Fatemi, N., Aghdaei, H. A., Niasar, M. S., Moghadam, P. K., Mojarad, E. N., Mini, E., & Nobili, S. (2023) · Cancers · doi:10.3390/cancers15102746 · Cited by 45 · see citing works
Combination of PD-L1 and PVR determines sensitivity to PD-1 blockade
Lee, B. R., Chae, S., Moon, J., Kim, M. J., Lee, H., Ko, H. W., Cho, B. C., Shim, H. S., Hwang, D., Kim, H. R., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.128633 · Cited by 43 · see citing works
Bayati-Komitaki, N., Ganduh, S. H., Alzaidy, A. H., & Salavati-Niasari, M. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117457 · Cited by 42 · see citing works
Nanomaterials-Mediated Immunomodulation for Cancer Therapeutics
Jindal, A., Sarkar, S., & Alam, A. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.629635 · Cited by 42 · see citing works
Jenkins, S. V., Robeson, M. S., Griffin, R. J., Quick, C. M., Siegel, E. R., Cannon, M. J., Vang, K. B., & Dings, R. P. M. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-4108 · Cited by 41 · see citing works
Daillère, R., Derosa, L., Bonvalet, M., Segata, N., Routy, B., Gariboldi, M., Budínská, E., de Vries, I. J. M., Naccarati, A., Zitvogel, V., et al. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1774298 · Cited by 38 · see citing works
Self-citationOrganoids Provide an Important Window on Inflammation in Cancer
Baker, K. (2018) · Cancers · doi:10.3390/cancers10050151 · Cited by 35 · see citing works
Zhang, Y., Yuan, T., Li, Z., Luo, C., Wu, Y., Zhang, J., Zhang, X., & Fan, W. (2021) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.1c00081 · Cited by 35 · see citing works
Mishra, S. B., Bhatt, T., Kumar, H., Jain, R., Shilpi, S., & Jain, V. K. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1101320 · Cited by 36 · see citing works
Urobiome in Gender—Related Diversities of Bladder Cancer
Bilski, K., Dobruch, J. T., Kozikowski, M., Skrzypczyk, M., Oszczudłowski, M., & Ostrowski, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124488 · Cited by 32 · see citing works
Gut Microbiota and Cancer of the Host: Colliding Interests
Baffy, G. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-34025-4_5 · Cited by 29 · see citing works
Xin, Y., Liu, C., Zang, D., & Chen, J. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1343450 · Cited by 30 · see citing works
Strategies for Predicting Response to Checkpoint Inhibitors
Zappasodi, R., Wolchok, J. D., & Merghoub, T. (2018) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-018-0471-9 · Cited by 29 · see citing works
Khanna, N., Chatterji, T., Singh, S., & Pandey, S. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104958 · Cited by 28 · see citing works
Cancer immunotherapy from biology to nanomedicine
Abdelbaky, S. B., Ibrahim, M. T., Samy, H., Mohamed, M., Mohamed, H., Mustafa, M., Abdelaziz, M. M., Forrest, M. L., & Khalil, I. A. H. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.06.025 · Cited by 27 · see citing works
Redrawing therapeutic boundaries: microbiota and cancer
Sholl, J., Sepich‐Poore, G. D., Knight, R. D., & Pradeu, T. (2021) · Trends in cancer · doi:10.1016/j.trecan.2021.10.008 · Cited by 28 · see citing works
Handling the Microbial Complexity Associated to Ticks
Cabezas‐Cruz, A., Pollet, T., Estrada‐Peña, A., Allain, E., Bonnet, S. I., & Moutailler, S. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.80511 · Cited by 27 · see citing works
Microbiome Crosstalk in Immunotherapy and Antiangiogenesis Therapy
Wan, X., Song, M., Wang, A., Zhao, Y., Wei, Z., & Lu, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.747914 · Cited by 26 · see citing works
Cilibrasi, C., Papanastasopoulos, P., Samuels, M. E., & Giamas, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222112015 · Cited by 26 · see citing works
Said, S., & Ibrahim, W. (2025) · Cancer Management and Research · doi:10.2147/cmar.s405590 · Cited by 25 · see citing works
Effects of PM2.5 exposure during gestation on maternal gut microbiota and pregnancy outcomes.
Liu, W., Zhou, Y.-L., Li, Y., Qin, Y., Yu, L.-L., Li, R.-J., Chen, Y., & Xu, Y.-J. (2020) · Chemosphere · doi:10.1016/j.chemosphere.2020.125879 · Cited by 23 · see citing works
Cancer Genomics in Precision Oncology: Applications, Challenges, and Prospects
Pereira, M. A., Kunrath‐Lima, M., Couto, P. G. P., Penna, M. G., Alvim, L. B., Nani, T. F., Freire, M. C. M., & Araujo, L. H. (2020) · Springer eBooks · doi:10.1007/978-981-15-1067-0_21 · Cited by 26 · see citing works
Li, J., Ruixue, C., Wang, C., Li, Y., Wu, B.-Y., & Wan, J. (2020) · Translational Cancer Research · doi:10.21037/tcr.2020.03.33 · Cited by 24 · see citing works
Cao, Y., He, H., Li, R., Liu, X., Chen, Y., Qi, Y., Yu, K., Wang, J., Lin, C., Liu, H., et al. (2020) · Annals of Surgery · doi:10.1097/sla.0000000000003833 · Cited by 24 · see citing works
Effect of Streptococcus anginosus on biological response of tongue squamous cell carcinoma cells
Xu, Y., Jia, Y., Chen, L., Gao, J., & Yang, D. (2021) · BMC Oral Health · doi:10.1186/s12903-021-01505-3 · Cited by 21 · see citing works
Zhu, C., Wang, S., Du, Y., Dai, Y., Huai, Q., Li, X., Du, Y., Dai, H., Yuan, W., Yin, S., et al. (2022) · BMC Gastroenterology · doi:10.1186/s12876-022-02532-2 · Cited by 21 · see citing works
Commensal Bifidobacterium Strains Enhance the Efficacy of Neo-Epitope Based Cancer Vaccines
Tomasi, M., Dalsass, M., Beghini, F., Zanella, I., Caproni, E., Fantappiè, L., Gagliardi, A., Irene, C., König, E., Frattini, L. F., et al. (2021) · Vaccines · doi:10.3390/vaccines9111356 · Cited by 18 · see citing works
Primary and acquired resistance to first-line therapy for clear cell renal cell carcinoma
Astore, S., Baciarello, G., Cerbone, L., & Calabrò, F. (2023) · Cancer Drug Resistance · doi:10.20517/cdr.2023.33 · Cited by 20 · see citing works
Wang, H., Yeh, T., Chan, L., Hsu, C., & Cho, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207621 · Cited by 19 · see citing works
Huang, Y., Zhang, W.-M., Wei, Z.-S., Huang, H., Mo, Q., Shi, D.-L., Han, L., Han, Y.-Y., Nong, S.-K., & Lin, G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1136169 · Cited by 18 · see citing works
Dong, X., Song, J., Chen, B., Qi, Y., Jiang, W., Li, H., Zheng, D., Wang, Y., Zhang, X., & Liu, H. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.592811 · Cited by 18 · see citing works
Tackling the Concept of Symbiotic Implantable Medical Devices with Nanobiotechnologies
Alcaraz, J., Cinquin, P., & Martin, D. K. (2018) · Biotechnology Journal · doi:10.1002/biot.201800102 · Cited by 17 · see citing works
Recent advancements in immunotherapy of melanoma using nanotechnology-based strategies
Bahreyni, A., Mohamud, Y., & Luo, H. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114243 · Cited by 16 · see citing works
Garrone, O., & Porta, C. A. M. L. (2024) · Cancers · doi:10.3390/cancers16040692 · Cited by 16 · see citing works
Daillère, R., Routy, B., Goubet, A., Cogdill, A. P., Ferrere, G., Silva, C. A.-C., Fluckiger, A., Ly, P., Haddad, Y., Pizzato, E., et al. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1794423 · Cited by 15 · see citing works
Self-citationThe role of the microbiome in pancreatic oncogenesis
Daley, D. (2022) · International Immunology · doi:10.1093/intimm/dxac036 · Cited by 14 · see citing works
Mocan, E. E., Yekedüz, E., Yekedüz, E., Karataş, G., Yazgan, S. C., Köksoy, E. B., Senler, F. C., Utkan, G., Demirkazık, A., Akbulut, H., et al. (2023) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000001498 · Cited by 15 · see citing works
Xu, C., Fang, H., Gu, Y., Yu, K., Wang, J., Lin, C., Zhang, H., Li, H., He, H., Liu, H., et al. (2022) · Cancer Science · doi:10.1111/cas.15537 · Cited by 13 · see citing works
Dall’Agnol, B., McCulloch, J. A., Mayer, F. Q., Souza, U. A., Webster, A., Rodrigues, P. A., Doyle, R. L., Reck, J., & Ferreira, C. A. S. (2021) · Ticks and Tick-borne Diseases · doi:10.1016/j.ttbdis.2021.101746 · Cited by 13 · see citing works
Tumor microenvironment-responsive metal nanotherapeutics for breast cancer chemo-/immunotherapy
Liu, J., Li, W., Lin, Y., Peng, Y., Zhan, M., Lai, H., Chang, Y., Li, Y., Wong, K., Chen, B., et al. (2023) · NPG Asia Materials · doi:10.1038/s41427-023-00473-0 · Cited by 13 · see citing works
Nasab, A. S., Banafshe, H. R., Atapour, A., Mahabady, M. K., Akbari, M., Daraei, A., Mansoori, Y., & Hasan‐Abad, A. M. (2024) · Frontiers in Medical Technology · doi:10.3389/fmedt.2023.1330007 · Cited by 13 · see citing works
Shen, Z., Gu, X., Cao, H., Mao, W., Yang, L., He, M. Y., Zhang, R., Zhou, Y., Liu, K., Wang, L., et al. (2021) · International Microbiology · doi:10.1007/s10123-021-00163-3 · Cited by 13 · see citing works
Zhao, C., Huang, Y., Zhang, H., & Liu, H. (2024) · Discover Oncology · doi:10.1007/s12672-024-01284-7 · Cited by 11 · see citing works
A highly branched α-d-glucan facilitates antitumor immunity by reducing cancer cell CXCL5 expression
Luo, Y., Li, C., He, T., Huang, W., Wang, Y., Yu, D. B., Ma, M., Yu, R., Zhu, J., & Song, L. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.03.217 · Cited by 11 · see citing works
Balasubramani, G., Muthu, M., Gopal, J., & Chun, S. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.127162 · Cited by 11 · see citing works
Advances in predicting breast cancer driver mutations: Tools for precision oncology (Review)
Hao, W., Rajendran, B. K., Cui, T., Sun, J., Yingchun, Z., Palaniyandi, T., & Selvam, M. (2024) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2024.5447 · Cited by 10 · see citing works
Gut Microbiome and the Response to Immunotherapy in Cancer
Stancu, A. L. (2018) · Discoveries · doi:10.15190/d.2018.4 · Cited by 12 · see citing works
Pyo, D. H., Hong, H. K., Lee, W. Y., & Cho, Y. B. (2020) · Cancer Biology & Therapy · doi:10.1080/15384047.2020.1738907 · Cited by 12 · see citing works
Intestinal Bacteria Encapsulated by Biomaterials Enhance Immunotherapy
Liu, Y., Li, Z., Wu, Y., Jing, X., Li, L., & Fang, X. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.620170 · Cited by 10 · see citing works
Emerging strategies in colorectal cancer immunotherapy: enhancing efficacy and survival
Zhang, Y., Guan, H., Feng, X., Liu, M., Shao, J., Liu, M., He, J., Jin, Y., Zhu, J., & Zheng, C. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1616414 · Cited by 8 · see citing works
Utilizing nanomaterials for cancer treatment and diagnosis: an overview
Mukhopadhyay, B., Singh, S., & Singh, A. (2024) · Discover Nano · doi:10.1186/s11671-024-04128-z · Cited by 7 · see citing works
Tfh cells set the stage for tumor control
King, C. (2021) · Immunity · doi:10.1016/j.immuni.2021.11.013 · Cited by 7 · see citing works
Anti-cancer Activity of Human Gastrointestinal BacteriaPreprint
Quazi, S. (2021) · Preprints.org · doi:10.20944/preprints202112.0433.v1 · Cited by 6 · see citing works
- Authors
- Kroemer, G., & Zitvogel, L.
- Affiliations
- Karolinska University Hospital (SE)
- Inserm (FR)
- Corresponding author
- Kroemer, Guido
- Zitvogel, Laurence
- Venue
- Nature Reviews Immunology
- Published
- 2018-01-30
- Volume
- 18
- Issue
- 2
- Pages
- 87-88
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2787841233
- Cited by
- 147
- References
- 11
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 14 · 2023: 17 · 2022: 17 · 2021: 33 · 2020: 23 · 2019: 19 · 2018: 13
- FWCI
- 7.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Seerave Foundation
- Ligue Contre le Cancer
- Fondation Gustave Roussy
- H2020 European Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Keywords
- gut microbiota, cancer immunotherapy, immunotherapy response, prognostic factors, antineoplastic therapy, mouse model, microbiota-targeted therapy
- MeSH terms
- Gastrointestinal Microbiome, Fecal Microbiota Transplantation, Animals, Humans, Immunotherapy, Neoplasms, Prognosis, Biomarkers, Tumor, Models, Immunological, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
